0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Tuberculosis Testing and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-16W8255
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Tuberculosis Testing and Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Tuberculosis Testing and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16W8255
Report
October 2024
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tuberculosis Testing and Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tuberculosis Testing and Diagnostics - Market

Tuberculosis Testing and Diagnostics - Market

Tuberculosis Testing and Diagnostics involve a range of medical procedures and tests used to detect and diagnose tuberculosis (TB) infections in individuals. These methods include the tuberculin skin test (TST), also known as the Mantoux test, and various blood tests that measure the immune response to TB-specific antigens. Advanced techniques like molecular tests (such as PCR) and chest X-rays can provide more accurate diagnoses, aiding in the detection of active TB infections or latent TB. Accurate TB diagnostics are crucial for timely treatment and controlling the spread of the disease.
The global market for Tuberculosis Testing and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Testing and Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tuberculosis Testing and Diagnostics by region & country, by Type, and by Application.
The Tuberculosis Testing and Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Testing and Diagnostics.
Market Segmentation

Scope of Tuberculosis Testing and Diagnostics - Market Report

Report Metric Details
Report Name Tuberculosis Testing and Diagnostics - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Thermo Fischer Scientific, Becton Dickinson, Abbott, Hologic, Qiagen, Sanofi, Oxford Immunotec, BioMerieux, Par Sterile, Bio-Rad Laboratories, Akonni Biosystems, Cepheid, Siemens Healthineer, Hain Lifescience, Epistem, Creative Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Tuberculosis Testing and Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Tuberculosis Testing and Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Tuberculosis Testing and Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Tuberculosis Testing and Diagnostics - Market report?

Ans: The main players in the Tuberculosis Testing and Diagnostics - Market are Roche, Thermo Fischer Scientific, Becton Dickinson, Abbott, Hologic, Qiagen, Sanofi, Oxford Immunotec, BioMerieux, Par Sterile, Bio-Rad Laboratories, Akonni Biosystems, Cepheid, Siemens Healthineer, Hain Lifescience, Epistem, Creative Diagnostics

What are the Application segmentation covered in the Tuberculosis Testing and Diagnostics - Market report?

Ans: The Applications covered in the Tuberculosis Testing and Diagnostics - Market report are Hospitals and Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Tuberculosis Testing and Diagnostics - Market report?

Ans: The Types covered in the Tuberculosis Testing and Diagnostics - Market report are Smear Microscopy, Nucleic Acid Testing, Radiography, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Others

Recommended Reports

Tuberculosis Diagnostics

Infectious Disease Diagnostics

General & Molecular Diagnostics

1 Market Overview
1.1 Tuberculosis Testing and Diagnostics Product Introduction
1.2 Global Tuberculosis Testing and Diagnostics Market Size Forecast
1.3 Tuberculosis Testing and Diagnostics Market Trends & Drivers
1.3.1 Tuberculosis Testing and Diagnostics Industry Trends
1.3.2 Tuberculosis Testing and Diagnostics Market Drivers & Opportunity
1.3.3 Tuberculosis Testing and Diagnostics Market Challenges
1.3.4 Tuberculosis Testing and Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuberculosis Testing and Diagnostics Players Revenue Ranking (2023)
2.2 Global Tuberculosis Testing and Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Tuberculosis Testing and Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tuberculosis Testing and Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Tuberculosis Testing and Diagnostics
2.6 Tuberculosis Testing and Diagnostics Market Competitive Analysis
2.6.1 Tuberculosis Testing and Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tuberculosis Testing and Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Smear Microscopy
3.1.2 Nucleic Acid Testing
3.1.3 Radiography
3.1.4 Tuberculin Skin Test (TST)
3.1.5 Interferon Gamma Released Assay (IGRA)
3.1.6 Others
3.2 Global Tuberculosis Testing and Diagnostics Sales Value by Type
3.2.1 Global Tuberculosis Testing and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tuberculosis Testing and Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Tuberculosis Testing and Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global Tuberculosis Testing and Diagnostics Sales Value by Application
4.2.1 Global Tuberculosis Testing and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis Testing and Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Tuberculosis Testing and Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tuberculosis Testing and Diagnostics Sales Value by Region
5.1.1 Global Tuberculosis Testing and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tuberculosis Testing and Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Tuberculosis Testing and Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Tuberculosis Testing and Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
5.2.2 North America Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
5.3.2 Europe Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
5.5.2 South America Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value
6.3 United States
6.3.1 United States Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.3.2 United States Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.4.2 Europe Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.5.2 China Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.6.2 Japan Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tuberculosis Testing and Diagnostics Sales Value, 2019-2030
6.9.2 India Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tuberculosis Testing and Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.1.4 Roche Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Thermo Fischer Scientific
7.2.1 Thermo Fischer Scientific Profile
7.2.2 Thermo Fischer Scientific Main Business
7.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.2.4 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fischer Scientific Recent Developments
7.3 Becton Dickinson
7.3.1 Becton Dickinson Profile
7.3.2 Becton Dickinson Main Business
7.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.3.4 Becton Dickinson Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Abbott Recent Developments
7.4 Abbott
7.4.1 Abbott Profile
7.4.2 Abbott Main Business
7.4.3 Abbott Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.4.4 Abbott Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Abbott Recent Developments
7.5 Hologic
7.5.1 Hologic Profile
7.5.2 Hologic Main Business
7.5.3 Hologic Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.5.4 Hologic Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Hologic Recent Developments
7.6 Qiagen
7.6.1 Qiagen Profile
7.6.2 Qiagen Main Business
7.6.3 Qiagen Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.6.4 Qiagen Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Qiagen Recent Developments
7.7 Sanofi
7.7.1 Sanofi Profile
7.7.2 Sanofi Main Business
7.7.3 Sanofi Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.7.4 Sanofi Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Sanofi Recent Developments
7.8 Oxford Immunotec
7.8.1 Oxford Immunotec Profile
7.8.2 Oxford Immunotec Main Business
7.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.8.4 Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Oxford Immunotec Recent Developments
7.9 BioMerieux
7.9.1 BioMerieux Profile
7.9.2 BioMerieux Main Business
7.9.3 BioMerieux Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.9.4 BioMerieux Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 BioMerieux Recent Developments
7.10 Par Sterile
7.10.1 Par Sterile Profile
7.10.2 Par Sterile Main Business
7.10.3 Par Sterile Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.10.4 Par Sterile Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Par Sterile Recent Developments
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Profile
7.11.2 Bio-Rad Laboratories Main Business
7.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.11.4 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Rad Laboratories Recent Developments
7.12 Akonni Biosystems
7.12.1 Akonni Biosystems Profile
7.12.2 Akonni Biosystems Main Business
7.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.12.4 Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Akonni Biosystems Recent Developments
7.13 Cepheid
7.13.1 Cepheid Profile
7.13.2 Cepheid Main Business
7.13.3 Cepheid Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.13.4 Cepheid Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Cepheid Recent Developments
7.14 Siemens Healthineer
7.14.1 Siemens Healthineer Profile
7.14.2 Siemens Healthineer Main Business
7.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.14.4 Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Siemens Healthineer Recent Developments
7.15 Hain Lifescience
7.15.1 Hain Lifescience Profile
7.15.2 Hain Lifescience Main Business
7.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.15.4 Hain Lifescience Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Hain Lifescience Recent Developments
7.16 Epistem
7.16.1 Epistem Profile
7.16.2 Epistem Main Business
7.16.3 Epistem Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.16.4 Epistem Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Epistem Recent Developments
7.17 Creative Diagnostics
7.17.1 Creative Diagnostics Profile
7.17.2 Creative Diagnostics Main Business
7.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Products, Services and Solutions
7.17.4 Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 Creative Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Tuberculosis Testing and Diagnostics Industrial Chain
8.2 Tuberculosis Testing and Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuberculosis Testing and Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Tuberculosis Testing and Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Tuberculosis Testing and Diagnostics Market Trends
    Table 2. Tuberculosis Testing and Diagnostics Market Drivers & Opportunity
    Table 3. Tuberculosis Testing and Diagnostics Market Challenges
    Table 4. Tuberculosis Testing and Diagnostics Market Restraints
    Table 5. Global Tuberculosis Testing and Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Tuberculosis Testing and Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Tuberculosis Testing and Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Tuberculosis Testing and Diagnostics
    Table 10. Global Tuberculosis Testing and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Tuberculosis Testing and Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Tuberculosis Testing and Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Tuberculosis Testing and Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Tuberculosis Testing and Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Tuberculosis Testing and Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Tuberculosis Testing and Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Tuberculosis Testing and Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Tuberculosis Testing and Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Tuberculosis Testing and Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Tuberculosis Testing and Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Tuberculosis Testing and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Tuberculosis Testing and Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Tuberculosis Testing and Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Tuberculosis Testing and Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Tuberculosis Testing and Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Basic Information List
    Table 32. Roche Description and Business Overview
    Table 33. Roche Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Roche (2019-2024)
    Table 35. Roche Recent Developments
    Table 36. Thermo Fischer Scientific Basic Information List
    Table 37. Thermo Fischer Scientific Description and Business Overview
    Table 38. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Thermo Fischer Scientific (2019-2024)
    Table 40. Thermo Fischer Scientific Recent Developments
    Table 41. Becton Dickinson Basic Information List
    Table 42. Becton Dickinson Description and Business Overview
    Table 43. Becton Dickinson Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Becton Dickinson (2019-2024)
    Table 45. Becton Dickinson Recent Developments
    Table 46. Abbott Basic Information List
    Table 47. Abbott Description and Business Overview
    Table 48. Abbott Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Abbott (2019-2024)
    Table 50. Abbott Recent Developments
    Table 51. Hologic Basic Information List
    Table 52. Hologic Description and Business Overview
    Table 53. Hologic Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Hologic (2019-2024)
    Table 55. Hologic Recent Developments
    Table 56. Qiagen Basic Information List
    Table 57. Qiagen Description and Business Overview
    Table 58. Qiagen Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Qiagen (2019-2024)
    Table 60. Qiagen Recent Developments
    Table 61. Sanofi Basic Information List
    Table 62. Sanofi Description and Business Overview
    Table 63. Sanofi Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Sanofi (2019-2024)
    Table 65. Sanofi Recent Developments
    Table 66. Oxford Immunotec Basic Information List
    Table 67. Oxford Immunotec Description and Business Overview
    Table 68. Oxford Immunotec Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Oxford Immunotec (2019-2024)
    Table 70. Oxford Immunotec Recent Developments
    Table 71. BioMerieux Basic Information List
    Table 72. BioMerieux Description and Business Overview
    Table 73. BioMerieux Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of BioMerieux (2019-2024)
    Table 75. BioMerieux Recent Developments
    Table 76. Par Sterile Basic Information List
    Table 77. Par Sterile Description and Business Overview
    Table 78. Par Sterile Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Par Sterile (2019-2024)
    Table 80. Par Sterile Recent Developments
    Table 81. Bio-Rad Laboratories Basic Information List
    Table 82. Bio-Rad Laboratories Description and Business Overview
    Table 83. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Bio-Rad Laboratories (2019-2024)
    Table 85. Bio-Rad Laboratories Recent Developments
    Table 86. Akonni Biosystems Basic Information List
    Table 87. Akonni Biosystems Description and Business Overview
    Table 88. Akonni Biosystems Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Akonni Biosystems (2019-2024)
    Table 90. Akonni Biosystems Recent Developments
    Table 91. Cepheid Basic Information List
    Table 92. Cepheid Description and Business Overview
    Table 93. Cepheid Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Cepheid (2019-2024)
    Table 95. Cepheid Recent Developments
    Table 96. Siemens Healthineer Basic Information List
    Table 97. Siemens Healthineer Description and Business Overview
    Table 98. Siemens Healthineer Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Siemens Healthineer (2019-2024)
    Table 100. Siemens Healthineer Recent Developments
    Table 101. Hain Lifescience Basic Information List
    Table 102. Hain Lifescience Description and Business Overview
    Table 103. Hain Lifescience Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Hain Lifescience (2019-2024)
    Table 105. Hain Lifescience Recent Developments
    Table 106. Epistem Basic Information List
    Table 107. Epistem Description and Business Overview
    Table 108. Epistem Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Epistem (2019-2024)
    Table 110. Epistem Recent Developments
    Table 111. Creative Diagnostics Basic Information List
    Table 112. Creative Diagnostics Description and Business Overview
    Table 113. Creative Diagnostics Tuberculosis Testing and Diagnostics Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Tuberculosis Testing and Diagnostics Business of Creative Diagnostics (2019-2024)
    Table 115. Creative Diagnostics Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Tuberculosis Testing and Diagnostics Downstream Customers
    Table 119. Tuberculosis Testing and Diagnostics Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Tuberculosis Testing and Diagnostics Product Picture
    Figure 2. Global Tuberculosis Testing and Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Tuberculosis Testing and Diagnostics Report Years Considered
    Figure 5. Global Tuberculosis Testing and Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Testing and Diagnostics Revenue in 2023
    Figure 7. Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Smear Microscopy Picture
    Figure 9. Nucleic Acid Testing Picture
    Figure 10. Radiography Picture
    Figure 11. Tuberculin Skin Test (TST) Picture
    Figure 12. Interferon Gamma Released Assay (IGRA) Picture
    Figure 13. Others Picture
    Figure 14. Global Tuberculosis Testing and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Tuberculosis Testing and Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals and Clinics
    Figure 17. Product Picture of Diagnostic Laboratories
    Figure 18. Product Picture of Others
    Figure 19. Global Tuberculosis Testing and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Tuberculosis Testing and Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Tuberculosis Testing and Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Tuberculosis Testing and Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Tuberculosis Testing and Diagnostics Sales Value (%), (2019-2030)
    Figure 32. United States Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Tuberculosis Testing and Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Tuberculosis Testing and Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Tuberculosis Testing and Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 53. Tuberculosis Testing and Diagnostics Industrial Chain
    Figure 54. Tuberculosis Testing and Diagnostics Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS